- Dr Lovorka Đerek and her team evaluated various tests as ANA screening, anti-dsDNA, anti-cardiolipin IgG and IgM, anti-B2GPI IgG and IgM, Anti-tTG IgA and anti-DGP, anti-MPO and anti-PR3.
- The obtained CVs for each marker met all the internal criteria as well as the ones stated by Sebia
- They pointed out the user-friendly software, as well as the flexibility of the random access automation.
- Not having to batch samples, combined with the small footprint of the device is found to be very practical

Tests associated with this resource
Related instrument
Any assay, any sample, any time!
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.
